{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:06:59Z","timestamp":1780096019526,"version":"3.54.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.tracli.2021.08.004","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T11:32:44Z","timestamp":1629113564000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Platelet transfusion practice and related transfusion reactions in a large teaching hospital"],"prefix":"10.1016","volume":"29","author":[{"given":"M.","family":"Liker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Bojani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Plenkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Luki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Tomac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6588-7886","authenticated-orcid":false,"given":"M.","family":"Raos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Golubi\u0107 \u0106epuli\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2021.08.004_bib0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JBM.S234374","article-title":"Platelet transfusion: an update on challenges and outcomes","volume":"11","author":"Alcaina","year":"2020","journal-title":"J Blood Med"},{"key":"10.1016\/j.tracli.2021.08.004_bib0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/tme.12155","article-title":"Why has demand for platelet components increased? A review","volume":"24","author":"Estcourt","year":"2014","journal-title":"Transfus Med"},{"key":"10.1016\/j.tracli.2021.08.004_bib0265","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/a-1347-6551","article-title":"Effects and side effects of platelet transfusion","volume":"41","author":"Cognasse","year":"2021","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.tracli.2021.08.004_bib0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tracli.2019.06.324","article-title":"Cytokines and related molecules, and adverse reactions related to platelet concentrate transfusions","volume":"26","author":"Cognasse","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fimmu.2015.00028","article-title":"Platelet transfusion\u00a0\u2013\u00a0The new immunology of an old therapy","volume":"6","author":"Stolla","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tmrv.2019.01.001","article-title":"Transfusion-transmitted infections reported to the national healthcare safety network hemovigilance module","volume":"33","author":"Haass","year":"2019","journal-title":"Trans Med Rev"},{"key":"10.1016\/j.tracli.2021.08.004_bib0285","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1537-2995.2009.02338.x","article-title":"Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks","volume":"49","author":"Vamvakas","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0290","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/MOH.0000000000000185","article-title":"Platelet transfusion and respecting patient D type","volume":"22","author":"Cid","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0295","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/trf.12498","article-title":"The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME)","volume":"54","author":"Tobian","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0300","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1182\/blood-2006-04-020131","article-title":"A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma","volume":"108","author":"Kerkhoffs","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.08.004_bib0305","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/trf.12597","article-title":"A comparison of adverse reaction rates for PAS C versus plasma platelet units","volume":"54","author":"Cohn","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0310","doi-asserted-by":"crossref","first-page":"108","DOI":"10.21307\/immunohematology-2020-024","article-title":"Quality improvement with platelet additive solution for safer out-of-group platelet transfusions","volume":"35","author":"Tynuv","year":"2019","journal-title":"Immunohematology"},{"key":"10.1016\/j.tracli.2021.08.004_bib0315","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/ajts.AJTS_150_17","article-title":"Adding to platelet safety and life: platelet additive solutions","volume":"12","author":"Mathur","year":"2018","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.tracli.2021.08.004_bib0320","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/trf.15138","article-title":"Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy","volume":"59","author":"Pagano","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-018-2114-x","article-title":"Platelet storage duration and its clinical and transfusion outcomes: a systematic review","volume":"22","author":"Aubron","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.tracli.2021.08.004_bib0330","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3389\/fimmu.2019.01478","article-title":"Platelet inflammatory response to stress","volume":"10","author":"Cognasse","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0335","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1537-2995.2011.03329.x","article-title":"Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence","volume":"52","author":"Henrichs","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0340","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood.V70.1.23.23","article-title":"An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients","volume":"70","author":"Heal","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.08.004_bib0345","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/vox.12354","article-title":"ABO-immune complex formation and impact on platelet function, red cell structural integrity and haemostasis: an in vitro model of ABO non-identical transfusion","volume":"110","author":"Zaffuto","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.004_bib0350","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1537-2995.2003.00326.x","article-title":"Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility","volume":"43","author":"Jim\u00e9nez","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0355","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.08.004_bib0360","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/bjh.13158","article-title":"Low frequency of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study","volume":"168","author":"Cid","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0365","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000501106","article-title":"Rhesus\u00a0D\u00a0Antigenic determinants on residual red blood cells in apheresis and buffy coat platelet concentrates","volume":"47","author":"Thibault","year":"2020","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.tracli.2021.08.004_bib0370","unstructured":"Popovsky MD, Robillard PD, Schipperus MD, Stainsby DD, Tissot J-DD, Wiersum-Osselton JD. Definitions for Surveillance of Non Infectious Transfusion Reaktions July 2011. Incorporating correction to TRALI definition (as adopted June 2013). Available from: http:\/\/www.ihn-org.com\/wp-content\/uploads\/2011\/06\/ISBT-definitions-fornon-infectious-transfusion-reactions.pdf."},{"key":"10.1016\/j.tracli.2021.08.004_bib0375","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqw191.032","article-title":"Platelet transfusion reactions with respect to transfusion indications: a single-center analysis","volume":"147","author":"Feldman","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0380","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/trf.15655","article-title":"ABO-incompatible platelets are associated with increased transfusion reaction rates","volume":"60","author":"Malvik","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0385","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/trf.12918","article-title":"Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012","volume":"55","author":"Harvey","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0390","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.htct.2019.09.006","article-title":"Determining the true incidence of acute transfusion reactions: active surveillance at a specialized liver center","volume":"42","author":"Sahu","year":"2020","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.tracli.2021.08.004_bib0395","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/vox.12234","article-title":"Passive reporting greatly underestimates the rate of transfusion-associated circulatory overload after platelet transfusion","volume":"108","author":"Raval","year":"2015","journal-title":"Vox Sang"},{"key":"10.1016\/j.tracli.2021.08.004_bib0400","first-page":"109","article-title":"Improving platelet transfusion safety: biomedical and technical considerations","volume":"14","author":"Garraud","year":"2016","journal-title":"Blood Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0405","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1537-2995.2007.01166.x","article-title":"Bacterial contamination of platelet concentrates: results of a prospective multicenter study comparing pooled whole blood-derived platelets and apheresis platelets","volume":"47","author":"Schrezenmeier","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0410","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/trf.12883","article-title":"Residual risk and retrospective analysis of transfusion-transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008","volume":"55","author":"Lafeuillade","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0415","doi-asserted-by":"crossref","first-page":"103717","DOI":"10.1016\/j.jprot.2020.103717","article-title":"Dysregulated pathways and differentially expressed proteins associated with adverse transfusion reactions in different types of platelet components","volume":"218","author":"Aloui","year":"2020","journal-title":"J Proteomics"},{"key":"10.1016\/j.tracli.2021.08.004_bib0420","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jprot.2018.12.019","article-title":"Differential protein expression of blood platelet components associated with adverse transfusion reactions","volume":"194","author":"Aloui","year":"2019","journal-title":"J Proteomics"},{"key":"10.1016\/j.tracli.2021.08.004_bib0425","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tracli.2018.03.002","article-title":"Transfusion-associated hazards: a revisit of their presentation","volume":"25","author":"Garraud","year":"2018","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.tracli.2018.07.006","article-title":"How to mitigate the risk of inducing transfusion-associated adverse reactions","volume":"25","author":"Garraud","year":"2018","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tracli.2021.08.004_bib0435","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/trf.12791","article-title":"Transfusion-related adverse events in the Platelet Dose study","volume":"55","author":"Kaufman","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0440","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1537-2995.2007.01613.x","article-title":"Patient and product factors affecting platelet transfusion results","volume":"48","author":"Heim","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0445","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1182\/blood-2017-03-773945","article-title":"Platelet soluble CD40-ligand level is associated with transfusion adverse reactions in a mixed threshold-and-hit model","volume":"130","author":"Cognasse","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tracli.2021.08.004_bib0450","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/trf.13077","article-title":"Easier said than done: ABO\u00a0compatibility and\u00a0D\u00a0matching in apheresis platelet transfusions","volume":"55","author":"Dunbar","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0455","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/trf.15637","article-title":"The epidemiology of platelet transfusions: an analysis of platelet use at 12 US hospitals","volume":"60","author":"Gottschall","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0460","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jprot.2009.08.002","article-title":"Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality","volume":"73","author":"Schubert","year":"2010","journal-title":"J Proteomics"},{"key":"10.1016\/j.tracli.2021.08.004_bib0465","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jprot.2012.06.023","article-title":"Optimization of platelet concentrate quality: application of proteomic technologies to donor management","volume":"76","author":"Schubert","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.tracli.2021.08.004_bib0470","first-page":"s63","article-title":"Profiling alterations in platelets induced by Amotosalen\/UVA pathogen reduction and gamma irradiation\u00a0\u2013\u00a0A LC-ESI-MS\/MS-based proteomics approach","volume":"10","author":"Thiele","year":"2012","journal-title":"Blood Transfus"},{"key":"10.1016\/j.tracli.2021.08.004_bib0475","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/trf.12060","article-title":"Proteomic analysis of platelets treated with gamma irradiation versus a commercial photochemical pathogen reduction technology","volume":"53","author":"Marrocco","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0480","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/trf.16207","article-title":"The effect of gamma irradiation on platelet redox state during storage","volume":"61","author":"Nodeh","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0485","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000363484","article-title":"Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance","volume":"41","author":"Julmy","year":"2014","journal-title":"Transfus Med Hemotherap"},{"issue":"11","key":"10.1016\/j.tracli.2021.08.004_bib0505","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1111\/trf.14882","article-title":"How I reduce the risk of missed irradiation transfusion events in children","volume":"58","author":"Delaney","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0495","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/trf.14359","article-title":"Analysis of pediatric adverse reactions to transfusions","volume":"58","author":"Vossoughi","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2021.08.004_bib0500","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/trf.12827","article-title":"Transfusion reactions in pediatric compared with adult patients: a look at rate, reaction type, and associated products","volume":"55","author":"Oakley","year":"2015","journal-title":"Transfusion"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678202100118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S124678202100118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:20Z","timestamp":1761129560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S124678202100118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S124678202100118X"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.004","relation":{},"ISSN":["1246-7820"],"issn-type":[{"value":"1246-7820","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet transfusion practice and related transfusion reactions in a large teaching hospital","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2021.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de transfusion sanguine (SFTS). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}